LianBio LLC

Industry · 7 registered clinical trials.

Status	Trial	Phase	Started
Terminated	Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinom Gastric Cancer, Gastroesophageal Junction Adenocarcinoma	Phase 2	2023-10-19
Terminated	BBP-398 in Combination With Osimertinib in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutations NSCLC	Phase 1	2023-07-27
Completed	Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study Blepharitis	Phase 3	2022-10-23
Terminated	Phase I Study of the BBP-398 in Patients With Advance Solid Tumors Advanced Solid Tumor, Advanced or Metastatic Non-small Cell Lung Cancer	Phase 1	2022-10-18
Completed	A Study to Evaluate the Efficacy and Safety of Mavacamten in Chinese Adults With Symptomatic Obstructive HCM Obstructive Hypertrophic Cardiomyopathy	Phase 3	2022-01-04
Completed	Study Evaluating the Pharmacokinetics of Mavacamten in Healthy Adult Chinese Subjects Hypertrophic Cardiomyopathy	Phase 1	2021-10-31
Unknown	Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterat Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Solid Tumor	Phase 2	2020-05-13